Skip to content
ClinCalc Pro
Menu
Sedating H1 antihistamine

Hydroxyzine hydrochloride

Brand names: Atarax, Ucerax

Hydroxyzine hydrochloride is a sedating first-generation (piperazine) antihistamine used in psychiatry for short-term anxiety and for pruritus, also exploiting its sedative properties.

Dosing — being independently re-sourced

ClinCalc Pro is rebuilding its dose data from primary open sources — the manufacturer SmPC (eMC), the WHO Model Formulary and other official references — under clinician review. This drug's structured dose is not yet published here. Confirm all doses against the product SmPC and your local formulary before prescribing.

Clinical monograph

How it works

It antagonises central and peripheral histamine H1 receptors, producing sedative, anxiolytic and antipruritic effects, with additional antimuscarinic activity.

Prescribing in practice

  • Hydroxyzine prolongs the QT interval and is contraindicated where there is known prolongation or significant risk factors, so avoid in cardiac risk, use the lowest effective dose for the shortest time, and avoid other QT-prolonging drugs.
  • Its antimuscarinic and sedative effects warrant caution in the elderly, in urinary retention, glaucoma and prostatic enlargement.
  • It potentiates alcohol and other central nervous system depressants and can impair driving and skilled tasks.

Monitoring

Monitor for excessive sedation, antimuscarinic effects and, where cardiac risk exists, QT-related concerns, with attention to the elderly.

Counselling the patient

  • Expect drowsiness and avoid driving or operating machinery if affected.
  • Avoid alcohol while taking this medicine.
  • Report palpitations or fainting, and use only for the short term as advised.

Evidence & guidelines

MHRA guidance restricting hydroxyzine to the lowest effective dose and shortest duration reflects its recognised risk of QT prolongation.

Reference: MHRA Drug Safety Update; Drug verified in RxNorm (NLM); confirm dosing against the manufacturer SPC (eMC). Verify against your local formulary and current prescribing references before prescribing. Monograph status: clinician-reviewed (2026-07-04).

Related

Curated clinical cross-links plus same-class fallbacks.